Exhibit 99.1
TENDER AND SUPPORT AGREEMENT
This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of August 8, 2023, is entered into by and among Regeneron Pharmaceuticals, Inc., a New York corporation (“Parent”), Symphony Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Purchaser”), and each of the persons set forth on Schedule A hereto (each, a “Stockholder” and together with Parent and Purchaser, the “Parties” and each, a “Party”). All terms used but not otherwise defined in this Agreement shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).
WHEREAS, as of the date hereof, each Stockholder is the record and beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of the number of Shares, Company Options and Company RSUs set forth opposite such Stockholder’s name on Schedule A (all such Shares, Company Options and Company RSUs and any other securities convertible into or exercisable or exchangeable or redeemable for Shares in which such Stockholder has record or beneficial ownership, and any additional Shares (and any Company Options, Company RSUs or any other securities convertible into or exercisable or exchangeable or redeemable for Shares) in which such Stockholder acquires record or beneficial ownership on or after the date hereof, whether by purchase, upon exercise or conversion of any securities or otherwise, the “Subject Shares”);
WHEREAS, Parent, Purchaser and Decibel Therapeutics, Inc., a Delaware corporation (the “Company”), have entered into an Agreement and Plan of Merger, dated as of the date hereof (as it may be amended from time to time, the “Merger Agreement”), which provides, among other things, for (a) Purchaser to commence an offer to purchase any (subject to the Minimum Condition) and all of the issued and outstanding Shares of the Company and the Merger, which if the Offer Acceptance Time occurs, shall be effected under Section 251(h) of the DGCL and (b) if an Offer Termination occurs, the Company to convene and hold the Company Stockholder Meeting for the purpose of obtaining the Company Stockholder Approval and to consummate the Merger pursuant to Section 251(c) of the DGCL, each upon the terms and subject to the conditions set forth in the Merger Agreement; and
WHEREAS, as a condition and inducement to the willingness of Parent and Purchaser to enter into the Merger Agreement, each Stockholder has agreed to enter into this Agreement.
NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows: